FDA Approved: CALQUENCE — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approves CALQUENCE (acalabrutinib) from AstraZeneca in an original application for mantle cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• CALQUENCE (ACALABRUTINIB)

Snippet

ORIG AP for CALQUENCE (ACALABRUTINIB)